West Pharmaceutical Services Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is West Pharmaceutical Services Inc 's ROA in the second quarter of 2026?
West Pharmaceutical Services Inc achieved a return on average assets (ROA) of 12.88 % in its second quarter of 2026, this is above WST's average return on assets of 11.64%.
West Pharmaceutical Services Inc s assets during the 12 months ending in the second quarter of 2026 are valued at $4 billion

ROA fell compared to the first quarter of 2026, despite the net income growth of 10.95% from the first quarter of 2026.

However, within the Healthcare sector 70 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 434, from total ROA ranking in the first quarter of 2026 at 551.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	31.07 %	13.59 %	21.49 %	12.8 %	18.06 %
Y / Y Net Income Change	16.84 %	54.57 %	1.54 %	2.94 %	18.42 %
Net Income (TTM) in million	565	543	494	492	488
Return On Assets (TTM)	12.88 %	13.3 %	12.48 %	13.05 %	13.35 %
WST's Total Ranking	# 434	# 551	# 454	# 425	# 429
Total Assets (TTM) in million	5,181	4,110	4,270	3,984	3,953
Seq. Total Assets Change	26.07 %	-3.75 %	7.17 %	0.8 %	9.25 %
Seq. Net Income Change	10.95 %	5.07 %	-5.64 %	6.22 %	46.77 %

WST's 5 Years Annual ROA >> Back to WST Management Effectiveness >> Compare WST ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 17
Sector	# 71
Overall	# 398

Return On Assets Statistics
High	Average	Low
21.82 %	11.64 %	4.59 %
(Dec 31 2021)		(Sep 30 2011)

Financial Statements
West Pharmaceutical Services Inc 's Assets	$ 5,181 million	WST's Balance sheet
West Pharmaceutical Services Inc 's Income	$ 154 million	Quarterly WST's Income Statement
WST's Income by Division		See WST's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	27.53 %	-5.17 %	7.44 %	7.84 %	17.95 %
Total Assets in million	4,482	3,515	3,706	3,450	3,199
Y / Y Net Income Change	0.2 %	-16.97 %	1.28 %	-11.47 %	91.16 %
Net Income in million	494	493	593	586	662
Annual Return On Assets	11.01 %	14.02 %	16.01 %	16.98 %	20.69 %

WST's 5 Years Annual ROA >> Back to WST Management Effectiveness >> Compare WST ROA to its Competitors

Comment on WST's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 11.01 %, despite annual net income growth of 0.2 % to $493.70 million, from $492.70 million a year ago, as WST's assets increase to $4,482.30 million, by 0.2 %.

More Return On Assets Ratios
WST's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
WST's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for WST's Competitors
Subscribers only: Roa for West Pharmaceutical Services Inc 's Suppliers
Subscribers only: Return On Assets for WST's Customers

You may also want to know
WST's Roi	WST's Inventory Turnover Ratio	WST's Growth Rates	WST's Dividend Comparisons
	WST's Profitability Ratios	WST's Asset Turnover Ratio	WST's Dividend Growth
WST's Roe	WST's Valuation Ratios	WST's Financial Strength Ratios	WST's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Ironwood Pharmaceuticals inc	34.34 %
Idexx Laboratories Inc	33.61 %
Tg Therapeutics Inc	33.59 %
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %

Date modified: 2026-07-24T15:19:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.